Long-term survival of participants in the prostate cancer prevention trial
The Prostate Cancer Prevention Trial (PCPT) is a seminal study in the field of urology. More than 10 years after its initial publication, updated data from this trial continue to shape our understanding of prostate cancer. Among the major findings from the PCPT has been the demonstration that prosta...
Main Authors: | Jonathan L Silberstein, Oliver Sartor |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-06-01
|
Series: | Asian Journal of Andrology |
Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=3;spage=413;epage=414;aulast=Silberstein |
Similar Items
-
Re: Long-term survival of participants in the Prostate Cancer Prevention Trial
by: Ian M Thompson, et al.
Published: (2014-06-01) -
Unexpected long-term survival in an adult patient with metastatic prostate cancer
by: P. Antonov, et al.
Published: (2021-07-01) -
Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells
by: Lee Tae-Jin, et al.
Published: (2004-11-01) -
Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
by: M. Kamrava, et al.
Published: (2009-01-01) -
Impact of clinical trial participation on survival in patients with castration-resistant prostate cancer: a multi-center analysis
by: Kyo Chul Koo, et al.
Published: (2018-04-01)